http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View More Recent Stories
-
Prothena Announces Appointment of Paula K. Cobb to its Board of Directors
-
Prothena Announces Appointment of Paula K. Cobb to its Board of Directors
-
Prothena to Participate in the Jefferies Healthcare Conference
-
Prothena to Participate in the Jefferies Healthcare Conference
-
Prothena Reports First Quarter 2019 Financial Results and Provides R&D Update
-
Prothena Reports First Quarter 2019 Financial Results and Provides R&D Update
-
Prothena to Report First Quarter 2019 Financial Results on May 7
-
Prothena to Report First Quarter 2019 Financial Results on May 7
-
Prothena Corp. (PRTA) Announces Results from Phase 3 VITAL Amyloidosis Study of NEOD001 (birtamimab) in AL Amyloidosis
-
Prothena Reports Results from the Phase 3 VITAL Amyloidosis Study of NEOD001 (birtamimab) in AL Amyloidosis
-
Prothena Reports Results from the Phase 3 VITAL Amyloidosis Study of NEOD001 (birtamimab) in AL Amyloidosis
-
Prothena to Participate in Upcoming March Healthcare Conferences
-
Prothena to Participate in Upcoming March Healthcare Conferences
-
Prothena Reports Fourth Quarter and Full Year 2018 Financial Results, and Provides Financial Guidance and R&D Update
-
Prothena Reports Fourth Quarter and Full Year 2018 Financial Results, and Provides Financial Guidance and R&D Update
-
Prothena to Report Fourth Quarter and Full Year 2018 Financial Results and Host Webcast Conference Call on February 14
-
Prothena to Report Fourth Quarter and Full Year 2018 Financial Results and Host Webcast Conference Call on February 14
-
Prothena Reports Third Quarter 2018 Financial Results and Provides R&D Update
-
Prothena Reports Third Quarter 2018 Financial Results and Provides R&D Update
-
Prothena to Report Third Quarter 2018 Financial Results on November 6
-
Prothena to Report Third Quarter 2018 Financial Results on November 6
-
Prothena Reports Second Quarter 2018 Financial Results and Provides R&D Update
-
Prothena Reports Second Quarter 2018 Financial Results and Provides R&D Update
-
Prothena to Report Second Quarter 2018 Financial Results on August 7
-
Prothena to Report Second Quarter 2018 Financial Results on August 7
-
Prothena Corp. (PRTA) Appoints Tran B. Nguyen as New COO
-
Prothena Announces Appointment of Tran B. Nguyen as Chief Operating Officer
-
Prothena Announces Appointment of Tran B. Nguyen as Chief Operating Officer
-
Prothena Announces Appointment of Tran B. Nguyen as Chief Operating Officer
-
Prothena Corp. (PRTA) Reports Publication of Phase 1b Clinical Trial Results of PRX002/RG7935 for Parkinson's Disease
-
Prothena Announces Phase 1b Clinical Trial Results of PRX002/RG7935 for Parkinson's Disease Published in JAMA Neurology
-
Prothena Announces Phase 1b Clinical Trial Results of PRX002/RG7935 for Parkinson's Disease Published in JAMA Neurology
-
Prothena Announces Phase 1b Clinical Trial Results of PRX002/RG7935 for Parkinson's Disease Published in JAMA Neurology
-
Prothena Corp. (PRTA) Announces Reorganization, Reports Discontinuation of NEOD001 Development Program
-
Prothena Announces Reorganization to Focus Resources on Advancing Neuroscience Pipeline
-
Prothena Announces Reorganization to Focus Resources on Advancing Neuroscience Pipeline
-
Prothena Announces Reorganization to Focus Resources on Advancing Neuroscience Pipeline
-
The Michael J. Fox Foundation and Prothena Partner to Accelerate Discovery of Novel Biomarkers for Parkinson's Disease

